Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer.
about
Progesterone receptors--animal models and cell signalling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancerAdvances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapyDeciphering the divergent roles of progestogens in breast cancer.A new strategy for selective targeting of progesterone receptor with passive antagonists.Oral contraceptives cause evolutionarily novel increases in hormone exposure: A risk factor for breast cancer.Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.The role of HLA-G in immunity and hematopoiesis.Tracking progesterone receptor-mediated actions in breast cancerInnovations in classical hormonal targets for endometriosis.Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes.The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature.Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein BimExpression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancerp38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targetsEffects of antiprogestins on the uterus.Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncology.Canine mammary tumours, an overview.Efficacy and pharmacogenomic biomarkers in breast cancer.Recent advances in structure of progestins and their binding to progesterone receptors.Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model.Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.Genomic and Nongenomic Effects of Mifepristone at the Cardiovascular Level: A Review.Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies.
P2860
Q24800251-807D2EE3-D75B-488A-AECC-6FFF4B14B427Q24803990-C777A9DF-B6F4-47B7-A06B-64BACBC0107CQ30240711-B41AE796-FC75-432B-8553-444132EF81F5Q33633141-2CE1980D-44C7-4504-9E15-072C692F339CQ33862767-E91CD18C-2FAB-4E81-AC48-89C0324994B5Q33909035-36C2B049-5837-4D10-9339-C1A6709F8B5CQ34024865-CEDDD1F0-6AC1-444B-9377-CE15DEBA294DQ34388848-85F20552-1C5B-46D7-AB55-7F6ADD04D518Q34504377-F6BA6D80-3073-4BFF-9A95-AC55BBA20035Q36027031-C4C9152F-A746-4DF6-87E8-9C0678A1B071Q36220795-0835228F-8517-44ED-AC3D-A148F5227841Q36245560-9652E935-D56D-403D-8341-1F3F7F802881Q36356432-4C7F4792-B2D4-4FCF-BD01-F37B8634DBE6Q36551958-B75941C0-DA82-489A-BB04-8CDB3A5EF4F1Q37056571-EBFBEF3A-D0A8-4B85-A583-7908551E5343Q37317295-F067E488-ADC1-42B1-B985-CB826F8DDB0AQ37346109-BD7B1EAC-3116-4FCC-B57E-7F21964FF08BQ37681583-BDEC0E32-DCAE-4894-AC83-B4EF563BF813Q37885436-C2A5C19B-DB80-418F-9FD9-9951CCD9D557Q37997046-034D0409-07B3-48E1-AD56-A3D1001179EBQ38199191-94FD6CC8-0C27-4C16-A112-3BFAB96268BBQ38789039-B7522FCC-5B8B-4EDE-86CB-47FE5DED9E57Q38855662-F57F23FD-94F1-42D3-AC7F-EB07976693BCQ38966345-3C9A7E5A-8CAC-4363-A87A-2C408196F16BQ39707882-E85F443C-23B7-4651-B658-41D16427241CQ43036142-18227807-793C-4123-92C0-7717C8582474Q45167319-A5723E7D-8E6D-4B8C-9156-695D9227E499
P2860
Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Progesterone antagonists and p ...... he treatment of breast cancer.
@ast
Progesterone antagonists and p ...... he treatment of breast cancer.
@en
type
label
Progesterone antagonists and p ...... he treatment of breast cancer.
@ast
Progesterone antagonists and p ...... he treatment of breast cancer.
@en
prefLabel
Progesterone antagonists and p ...... he treatment of breast cancer.
@ast
Progesterone antagonists and p ...... he treatment of breast cancer.
@en
P2093
P1433
P1476
Progesterone antagonists and p ...... he treatment of breast cancer.
@en
P2093
Foekens JA
Setyono-Han B
P304
P356
10.1016/S0039-128X(00)00195-1
P577
2000-10-01T00:00:00Z